Levothyroxine Sodium Tablet · 22 active FDA presentation rows for this drug
Brand: EUTHYROX
FDA lists Levothyroxine Sodium Tablet as To Be Discontinued (EMD Serono, Inc.).
No availability text on this FDA row.
Levothyroxine Sodium Tablet: To Be Discontinued
FDA availability text is not recorded on this row. 22 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Levothyroxine Sodium Tablet
- Manufacturer
- EMD Serono, Inc.
- Dosage Form
- Tablet
- Presentation
- Euthyrox, Tablet, 100 ug (NDC 72305-100-90)
- Package NDC
- 72305-100-90
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jul 10, 2025
- Last Updated
- Jul 10, 2025
- Therapeutic Category
- Endocrinology/Metabolism
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
levothyroxine
Side effects, interactions, warnings & more
Nearby, Other Levothyroxine Shortage Records
Levothyroxine Sodium Tablet
EMD Serono, Inc.
Tablet
Levothyroxine Sodium Tablet
EMD Serono, Inc.
Tablet
Levothyroxine Sodium Tablet
EMD Serono, Inc.
Tablet
Levothyroxine Sodium Tablet
EMD Serono, Inc.
Tablet
Levothyroxine Sodium Tablet
EMD Serono, Inc.
Tablet
Levothyroxine Sodium Tablet
EMD Serono, Inc.
Tablet
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.